C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever

International Journal of Infectious Diseases

Volumn 16, Issue 8, 2012, Pages

  Turkdogan, Kenan Ahmet ^a   Zorlu, Ali ^b   Engin, Aynur ^c   Guven, Fatma Mutlu Kukul ^a   Polat, Muhammed Mirhan ^c   Turgut, Okan Onur ^c   Yilmaz, Mehmet Birhan ^c  

^a ISPARTA STATE HOSPITAL   (Turkey)

^b Bulanik State Hospital   (Turkey)

^c CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

C type natriuretic peptide; Crimean Congo hemorrhagic fever; Risk stratification

Indexed keywords

ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; NATRIURETIC PEPTIDE TYPE C;

ADULT; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; CRITICAL ILLNESS; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROGNOSIS; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; UNIVARIATE ANALYSIS; VASCULAR DISEASE;

ADULT; AGED; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; PROGNOSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84864395552     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.04.009     Document Type: Article

References (27)

1. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res 2004, 64:145-160.
2. Ergonul O., Celikbas A., Dokuzoguz B., Eren S., Baykam N., Esener H. The characteristics of Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clin Infect Dis 2004, 39:285-289.
3. Schnittler H.J., Feldman H. Viral hemorrhagic fever-a vascular disease?. Thromb Haemost 2003, 89:967-972.
4. Sannikova I.V., Pacechnikov V.D., Maleev V.V. Respiratory lesions in Crimean-Congo hemorrhagic fever. Ter Arkh 2007, 79:20-23.
5. Doganci L., Ceyhan M., Tasdeler N.F., Sarikayalar H., Tulek N. Crimean-Congo hemorrhagic fever and diffuse alveolar haemorrhage. Trop Doct 2008, 38:252-254.
6. Rubattu S., Sciarretta S., Valenti V., Stanzione R., Volpe M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008, 21:733-741.
7. Garbers D.L., Chrisman T.D., Wiegn P., Katafuchi T., Albanesi J.P., Bielinski V., et al. Membrane guanylyl cyclase receptors: an update. Trends Endocrinol Metab 2006, 17:251-258.
8. Heublein D.M., Clavell A.L., Stingo A.J., Lerman A., Wold L., Burnett J.C. C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides 1992, 13:1017-1019.
9. Barr C.S., Rhodes P., Struthers A.D. C-type natriuretic peptide. Peptides 1996, 17:1243-1251.
10. Hama N., Itoh H., Shirakami G., Suga S., Komatsu Y., Yoshimasa T., et al. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994, 198:1177-1182.
11. Bahrami S., Pelinka L., Khadem A., Maitzen S., Hawa G., van Griensven M., et al. Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury. Crit Care Med 2010, 38:161-166.
12. Yapar M., Aydogan H., Pahsa A., Besirbellioglu B.A., Bodur H., Basustaoglu A.C., et al. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn J Infect Dis 2005, 58:358-362.
13. Cevik M.A., Erbay A., Bodur H., Gulderen E., Bastug A., Kubar A., et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008, 12:374-379.
14. Swanepoel R., Gill D.E., Shepherd A.J., Leman P.A., Mynhardt J.H., Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989, 11:794-800.
15. Ergonul O., Celikbas A., Baykam N., Eren S., Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006, 12:551-554.
16. Yilmaz G., Mentese A., Kaya S., Uzun A., Karahan S.C., Koksal I. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever. J Clin Virol 2011, 50:209-211.
17. Ozturk B., Kuscu F., Tutuncu E., Sencan I., Gurbuz Y., Tuzun H. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J Clin Virol 2010, 47:115-119.
18. Bodur H., Akinci E., Ongürü P., Uyar Y., Baştürk B., Gözel M.G., et al. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis 2010, 14:704-707.
19. Joubert J.R., King J.B., Rossouw D.J., Cooper R. A nosocomial outbreak of Crimean- Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S Afr Med J 1985, 68:722-728.
20. Koch A., Voigt S., Sanson E., Dückers H., Horn A., Zimmermann H.W., et al. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients. Crit Care 2011, 15:R45.
21. Vlachopoulos C., Ioakeimidis N., Terentes-Printzios D., Aznaouridis K., Baou K., Bratsas A., et al. Amino-terminal pro-C-type natriuretic peptide is associated with arterial stiffness, endothelial function and early atherosclerosis. Atherosclerosis 2010, 211:649-655.
22. Burt F.J., Swanepoel R., Shieh W.J., Smith J.F., Leman P.A., Greer P.W., et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 1997, 121:839-846.
23. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006, 6:203-214.
24. Appannanavar S.B., Mishra B. An update on Crimean Congo hemorrhagic fever. J Glob Infect Dis 2011, 3:285-292.
25. Ergonul O., Tuncbilek S., Baykam N., Celikbas A., Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006, 193:941-944.
26. Papa A., Bino S., Velo E., Harxhi A., Kota M., Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 2006, 36:272-276.
27. Engin A., Arslan S., Kizildag S., Oztürk H., Elaldi N., Dökmetas I., et al. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microbes Infect 2010, 12:1071-1078.